As sailnyssa astutely observed in another MSB thread, of the last half dozen or so decisions by the FDA, all of treatments with priority review had a a positive FDA decision on or before the relevant decision date.
These is just the facts that sailnyssa put forward. I dont think it necessarily reflects all FDA decisions, but certainly the recent ones.
On that basis, no news by open on Thursday might suggest bad news for MSB.
MSB Trading 2020 - a new dawn, page-5872
-
- There are more pages in this discussion • 7,199 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.07 |
Change
0.013(1.18%) |
Mkt cap ! $1.233B | |||
| Open | High | Low | Value | Volume |
| $1.08 | $1.10 | $1.06 | $2.511M | 2.328M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 21 | 49002 | $1.07 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.08 | 82613 | 22 |
View Market Depth
| Last trade - 14.57pm 03/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |